PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity

Sridharan Manavalan, Bruk Getachew, Kebreten F. Manaye, Syed J. Khundmiri, Antonei B. Csoka, Raechel McKinley, A. Tamás, D. Reglodi, Yousef Tizabi

Research output: Article

12 Citations (Scopus)

Abstract

The detrimental effects of heavy drinking and smoking are multiplied when the two are combined. Treatment modalities for each and especially for the combination are very limited. Although in low concentration, alcohol and nicotine, each may have beneficial effects including neuroprotection, their combination, instead of providing additive protection, may actually lead to toxicity in cell cultures. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous 38 amino-acid peptide with demonstrated protection against neuronal injury, trauma as well as various endogenous and exogenous toxic agents. The aim of this study was to investigate whether PACAP may also protect against toxicity induced by high alcohol, high nicotine, or the combination of low alcohol and nicotine concentrations, and if so, whether this effect was mediated via PAC1 receptor. We used the neuroblastoma-derived SH-SY5Y cells and applied various colorimetric assays for determination of cell viability or toxicity. Results indicate that PACAP blocks toxicity induced by high alcohol and high nicotine as well as their combination at low concentrations. The effects of PACAP in turn were blocked by the PACAP antagonist (PACAP 6-38), indicating involvement of the PACAP receptor PAC1 and possibly vasoactive intestinal peptide (VIP) receptors in PACAP’s protection. Moreover, no combined toxicity of low alcohol and low nicotine could be detected in calcium-free medium. These findings suggest possible beneficial effects of PACAP in preventing alcohol and nicotine toxicity and that calcium contributes to the damage induced by combination of low alcohol and nicotine in SH-SY5Y cells.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalNeurotoxicity Research
DOIs
Publication statusAccepted/In press - márc. 24 2017

Fingerprint

Pituitary Adenylate Cyclase-Activating Polypeptide
Nicotine
Drinking
Toxicity
Ethanol
Smoking
Morbidity
Alcohols
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
Pituitary Adenylate Cyclase-Activating Polypeptide Receptors
Vasoactive Intestinal Peptide Receptors
Calcium
Poisons
Wounds and Injuries
Neuroblastoma
Cell culture
Assays
Cell Survival
Cell Culture Techniques
Cells

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Manavalan, S., Getachew, B., Manaye, K. F., Khundmiri, S. J., Csoka, A. B., McKinley, R., ... Tizabi, Y. (Accepted/In press). PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity. Neurotoxicity Research, 1-6. https://doi.org/10.1007/s12640-017-9727-8

PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells : Implications for Drinking-Smoking Co-morbidity. / Manavalan, Sridharan; Getachew, Bruk; Manaye, Kebreten F.; Khundmiri, Syed J.; Csoka, Antonei B.; McKinley, Raechel; Tamás, A.; Reglodi, D.; Tizabi, Yousef.

In: Neurotoxicity Research, 24.03.2017, p. 1-6.

Research output: Article

Manavalan, Sridharan ; Getachew, Bruk ; Manaye, Kebreten F. ; Khundmiri, Syed J. ; Csoka, Antonei B. ; McKinley, Raechel ; Tamás, A. ; Reglodi, D. ; Tizabi, Yousef. / PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells : Implications for Drinking-Smoking Co-morbidity. In: Neurotoxicity Research. 2017 ; pp. 1-6.
@article{5b09f7cd1eb34cbd856282442d865d4b,
title = "PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity",
abstract = "The detrimental effects of heavy drinking and smoking are multiplied when the two are combined. Treatment modalities for each and especially for the combination are very limited. Although in low concentration, alcohol and nicotine, each may have beneficial effects including neuroprotection, their combination, instead of providing additive protection, may actually lead to toxicity in cell cultures. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous 38 amino-acid peptide with demonstrated protection against neuronal injury, trauma as well as various endogenous and exogenous toxic agents. The aim of this study was to investigate whether PACAP may also protect against toxicity induced by high alcohol, high nicotine, or the combination of low alcohol and nicotine concentrations, and if so, whether this effect was mediated via PAC1 receptor. We used the neuroblastoma-derived SH-SY5Y cells and applied various colorimetric assays for determination of cell viability or toxicity. Results indicate that PACAP blocks toxicity induced by high alcohol and high nicotine as well as their combination at low concentrations. The effects of PACAP in turn were blocked by the PACAP antagonist (PACAP 6-38), indicating involvement of the PACAP receptor PAC1 and possibly vasoactive intestinal peptide (VIP) receptors in PACAP’s protection. Moreover, no combined toxicity of low alcohol and low nicotine could be detected in calcium-free medium. These findings suggest possible beneficial effects of PACAP in preventing alcohol and nicotine toxicity and that calcium contributes to the damage induced by combination of low alcohol and nicotine in SH-SY5Y cells.",
keywords = "Alcohol, Calcium, Neuroprotection, Neurotoxicity, Nicotine, PACAP, SH-SY5Y cell line",
author = "Sridharan Manavalan and Bruk Getachew and Manaye, {Kebreten F.} and Khundmiri, {Syed J.} and Csoka, {Antonei B.} and Raechel McKinley and A. Tam{\'a}s and D. Reglodi and Yousef Tizabi",
year = "2017",
month = "3",
day = "24",
doi = "10.1007/s12640-017-9727-8",
language = "English",
pages = "1--6",
journal = "Neurotoxicity Research",
issn = "1029-8428",
publisher = "Springer New York",

}

TY - JOUR

T1 - PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells

T2 - Implications for Drinking-Smoking Co-morbidity

AU - Manavalan, Sridharan

AU - Getachew, Bruk

AU - Manaye, Kebreten F.

AU - Khundmiri, Syed J.

AU - Csoka, Antonei B.

AU - McKinley, Raechel

AU - Tamás, A.

AU - Reglodi, D.

AU - Tizabi, Yousef

PY - 2017/3/24

Y1 - 2017/3/24

N2 - The detrimental effects of heavy drinking and smoking are multiplied when the two are combined. Treatment modalities for each and especially for the combination are very limited. Although in low concentration, alcohol and nicotine, each may have beneficial effects including neuroprotection, their combination, instead of providing additive protection, may actually lead to toxicity in cell cultures. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous 38 amino-acid peptide with demonstrated protection against neuronal injury, trauma as well as various endogenous and exogenous toxic agents. The aim of this study was to investigate whether PACAP may also protect against toxicity induced by high alcohol, high nicotine, or the combination of low alcohol and nicotine concentrations, and if so, whether this effect was mediated via PAC1 receptor. We used the neuroblastoma-derived SH-SY5Y cells and applied various colorimetric assays for determination of cell viability or toxicity. Results indicate that PACAP blocks toxicity induced by high alcohol and high nicotine as well as their combination at low concentrations. The effects of PACAP in turn were blocked by the PACAP antagonist (PACAP 6-38), indicating involvement of the PACAP receptor PAC1 and possibly vasoactive intestinal peptide (VIP) receptors in PACAP’s protection. Moreover, no combined toxicity of low alcohol and low nicotine could be detected in calcium-free medium. These findings suggest possible beneficial effects of PACAP in preventing alcohol and nicotine toxicity and that calcium contributes to the damage induced by combination of low alcohol and nicotine in SH-SY5Y cells.

AB - The detrimental effects of heavy drinking and smoking are multiplied when the two are combined. Treatment modalities for each and especially for the combination are very limited. Although in low concentration, alcohol and nicotine, each may have beneficial effects including neuroprotection, their combination, instead of providing additive protection, may actually lead to toxicity in cell cultures. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous 38 amino-acid peptide with demonstrated protection against neuronal injury, trauma as well as various endogenous and exogenous toxic agents. The aim of this study was to investigate whether PACAP may also protect against toxicity induced by high alcohol, high nicotine, or the combination of low alcohol and nicotine concentrations, and if so, whether this effect was mediated via PAC1 receptor. We used the neuroblastoma-derived SH-SY5Y cells and applied various colorimetric assays for determination of cell viability or toxicity. Results indicate that PACAP blocks toxicity induced by high alcohol and high nicotine as well as their combination at low concentrations. The effects of PACAP in turn were blocked by the PACAP antagonist (PACAP 6-38), indicating involvement of the PACAP receptor PAC1 and possibly vasoactive intestinal peptide (VIP) receptors in PACAP’s protection. Moreover, no combined toxicity of low alcohol and low nicotine could be detected in calcium-free medium. These findings suggest possible beneficial effects of PACAP in preventing alcohol and nicotine toxicity and that calcium contributes to the damage induced by combination of low alcohol and nicotine in SH-SY5Y cells.

KW - Alcohol

KW - Calcium

KW - Neuroprotection

KW - Neurotoxicity

KW - Nicotine

KW - PACAP

KW - SH-SY5Y cell line

UR - http://www.scopus.com/inward/record.url?scp=85016022783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016022783&partnerID=8YFLogxK

U2 - 10.1007/s12640-017-9727-8

DO - 10.1007/s12640-017-9727-8

M3 - Article

C2 - 28342135

AN - SCOPUS:85016022783

SP - 1

EP - 6

JO - Neurotoxicity Research

JF - Neurotoxicity Research

SN - 1029-8428

ER -